135 related articles for article (PubMed ID: 6432001)
1. Acute and chronic hypotensive effects of nifedipine and niludipine in hypertensive patients with chronic renal failure.
Kusano E; Asano Y; Takeda K; Terao N; Hosoda S
Arzneimittelforschung; 1984; 34(5):624-9. PubMed ID: 6432001
[TBL] [Abstract][Full Text] [Related]
2. Acute hypotensive, hemodynamic effects of long-term treatment with niludipine, a Ca2+-antagonist, in patients with essential hypertension. Niludipine monotherapy and combination with a beta-blocker and a diuretic).
Aoki K; Sato K
Arzneimittelforschung; 1982; 32(9):1141-5. PubMed ID: 6756418
[TBL] [Abstract][Full Text] [Related]
3. Hypotensive effect of nifedipine in hypertensive patients with chronic renal failure.
Kusano E; Asano Y; Takeda K; Matsumoto Y; Ebihara A; Hosoda S
Arzneimittelforschung; 1982; 32(12):1575-80. PubMed ID: 6760869
[TBL] [Abstract][Full Text] [Related]
4. Antihypertensive effects of long-acting calcium channel blockers on hemodialysis days--a randomized crossover trial between benidipine and nifedipine CR.
Kojima M; Taniguchi M; Sato K; Ueda R; Dohi Y
Nephron Clin Pract; 2004; 97(2):c49-53. PubMed ID: 15218330
[TBL] [Abstract][Full Text] [Related]
5. Antihypertensive effect of Niludipine (Bay a 7168) on conscious renal-hypertensive dogs.
Hiwatari M; Taira N
Arzneimittelforschung; 1979; 29(9):1373-6. PubMed ID: 583244
[TBL] [Abstract][Full Text] [Related]
6. A study on the effects of niludipine in hypertensive patients.
Kuwajima I; Ueda K; Murakami M
Arzneimittelforschung; 1982; 32(4):398-402. PubMed ID: 7201809
[TBL] [Abstract][Full Text] [Related]
7. Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients.
de Champlain J; Karas M; Nguyen P; Cartier P; Wistaff R; Toal CB; Nadeau R; Larochelle P
J Hypertens; 1998 Nov; 16(11):1357-69. PubMed ID: 9856375
[TBL] [Abstract][Full Text] [Related]
8. Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients.
de Champlain J; Karas M; Nguyen P; Cartier P; Wistaff R; Toal CB; Nadeau R; Larochelle P
J Hypertens; 1998 Sep; 16(9):1357-69. PubMed ID: 9746123
[TBL] [Abstract][Full Text] [Related]
9. Antihypertensive effects of the calcium antagonistic agent nifedipine.
Maeda K; Tanaka C; Tsukano Y; Minamikawa H; Komatsu H; Kotsumi K; Inoue E
Arzneimittelforschung; 1982; 32(3):267-71. PubMed ID: 7200785
[TBL] [Abstract][Full Text] [Related]
10. A comparison of the safety and efficacy of mibefradil and nifedipine SR in patients with renal disease and hypertension.
Woittiez AJ; Huysmans FT; Bailey R; Robson RA; Mion Júnior D; Villa G; Kobrin I
Clin Nephrol; 1998 Mar; 49(3):160-6. PubMed ID: 9543597
[TBL] [Abstract][Full Text] [Related]
11. Clinical efficacy of niludipine in the treatment of angina pectoris.
Yasuda H; Tomita T; Fujita K; Shibata J; Tateda K; Yokota H; Igarashi T; Ogasawara S; Yamazaki M; Oyama Y
Arzneimittelforschung; 1984; 34(5):614-9. PubMed ID: 6540580
[TBL] [Abstract][Full Text] [Related]
12. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine.
Kes S; Caglar N; Canberk A; Deger N; Demirtas M; Dortlemez H; Kiliccioglu B; Kozan O; Ovunc K; Turkoglu C
Curr Med Res Opin; 2003; 19(3):226-37. PubMed ID: 12803737
[TBL] [Abstract][Full Text] [Related]
13. [Hypotensive properties of nisoldipine. Comparative study in essential, renal and renovascular hypertension].
Wambach G; Breuer G; Kaufmann W
Arzneimittelforschung; 1984; 34(5):620-3. PubMed ID: 6540581
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of sublingual verapamil in patients with severe essential hypertension: comparison with sublingual nifedipine.
Al-Waili NS; Hasan NA
Eur J Med Res; 1999 May; 4(5):193-8. PubMed ID: 10336409
[TBL] [Abstract][Full Text] [Related]
15. Comparative effects of felodipine ER, amlodipine and nifedipine GITS on 24 h blood pressure control and trough to peak ratios in mild to moderate ambulatory hypertension: a forced titration study.
Lefebvre J; Poirier L; Archambault F; Jewell D; Reed CV; Lacourcière Y
Can J Cardiol; 1998 May; 14(5):682-8. PubMed ID: 9627524
[TBL] [Abstract][Full Text] [Related]
16. Clinical effectiveness of niludipine in patients with ischemic heart disease.
Ogawa K; Ito T; Ban M; Hashimoto H; Nizoe K; Mochizuki M; Sakai K; Watanabe J; Kanayama H; Okumura K; Sone T; Imura K; Uno T; Shikano M; Kotaka K; Miyazaki Y
Arzneimittelforschung; 1982; 32(5):542-7. PubMed ID: 6809015
[TBL] [Abstract][Full Text] [Related]
17. Dose- and administration time-dependent effects of nifedipine gits on ambulatory blood pressure in hypertensive subjects.
Hermida RC; Calvo C; Ayala DE; López JE; Rodríguez M; Chayán L; Mojón A; Fontao MJ; Fernández JR
Chronobiol Int; 2007; 24(3):471-93. PubMed ID: 17612946
[TBL] [Abstract][Full Text] [Related]
18. An oral calcium antagonist for treatment of hypertensive emergencies.
Conen D; Bertel O; Dubach UC
J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S378-82. PubMed ID: 6184572
[TBL] [Abstract][Full Text] [Related]
19. Study population and treatment titration in the International Nifedipine GITS Study: Intervention as a Goal in Hypertension Treatment (INSIGHT).
Brown MJ; Castaigne A; de Leeuw PW; Mancia G; Rosenthal T; Ruilope LM
J Hypertens; 1998 Dec; 16(12 Pt 2):2113-6. PubMed ID: 9886905
[TBL] [Abstract][Full Text] [Related]
20. Effect of slow release nifedipine tablets in patients with essential hypertension.
Imai Y; Abe K; Munakata M; Sasaki S; Minami N; Sakuma H; Hashimoto J; Watanabe N; Sakuma M; Sekino H
Arzneimittelforschung; 1992 Dec; 42(12):1434-8. PubMed ID: 1288507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
